ReviewWorld journal of microbiology & biotechnology2026
Microbial production of xanthohumol driven by synthetic biology approaches.
Review in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Xanthohumol is a high-value natural product with unique features, such as its antioxidant, anti-inflammatory, and anticancer properties. The excellent features enable its wide utilization in the cosmetic, pharmaceutical, nutraceutical, and food industries. However, the low yields and high production costs impede its large-scale production significantly. Its sustainable production has been limited by inefficient, costly, and environmentally unfriendly conventional extraction processes. Recently, the development of microbial synthetic biology has provided a reliable, scalable, and eco-friendly mechanism for xanthohumol production. In this paper, the development of bio-strategies for the commercial-scale production of xanthohumol is summarized. Furthermore, the techno-economic feasibility was also evaluated. In the future, further attempt will still be required for xanthohumol production using synthetic biology.
Indexed as
Identifiers
42189397What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.